We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
-4.03%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$29.4B
AUM Growth
-$873M
(-2.9%)
Cap. Flow
+$534M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
SFL Corp
SFL
$1.63B
| $4.55M | 0.02% |
499,627
+1,406
| +0.3% | +$14.2K |
|
|
AKRO
777
DELISTED
Akero Therapeutics
AKRO
| $4.55M | 0.02% |
133,547
+66,911
| +100% | +$1.02M |
|
|
YELL
778
DELISTED
Yellow Corporation Common Stock
YELL
| $4.49M | 0.02% |
885,841
-85,481
| -9% | -$469K |
|
779
Gogo Inc
GOGO
$347M
| $4.48M | 0.02% |
369,667
-204,734
| -36% | -$3.11M |
|
|
TCDA
780
DELISTED
Tricida, Inc. Common Stock
TCDA
| $4.47M | 0.02% |
426,964
+76,365
| +22% | +$835K |
|
781
Jazz Pharmaceuticals
JAZZ
$16.5B
| $4.46M | 0.02% |
33,500
-59,756
| -64% | -$9.09M |
|
782
BJ's Restaurants
BJRI
$1.43B
| $4.45M | 0.02% |
186,538
+70,383
| +61% | +$1.73M |
|
783
LXP Industrial Trust
LXP
$3.6B
| $4.45M | 0.02% |
97,104
-38,864
| -29% | -$2.02M |
|
784
Four Corners Property Trust
FCPT
$2.8B
| $4.44M | 0.02% |
183,595
+27,520
| +18% | +$755K |
|
785
Essent Group
ESNT
$6.15B
| $4.4M | 0.01% |
126,066
+73,888
| +142% | +$2.96M |
|
786
iShares US Consumer Staples ETF
IYK
$1.44B
| $4.39M | 0.01% |
73,200
+47,100
| +180% | +$3.09M |
|
787
Silicon Laboratories
SLAB
$7.28B
| $4.37M | 0.01% |
+35,369
| New | +$4.73M |
|
|
ROIC
788
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $4.36M | 0.01% |
316,866
-335,644
| -51% | -$5.54M |
|
789
Aspen Aerogels
ASPN
$416M
| $4.36M | 0.01% |
472,601
-80,946
| -15% | -$980K |
|
790
AtriCure
ATRC
$2.51B
| $4.36M | 0.01% |
111,369
+33,745
| +43% | +$1.54M |
|
|
KDNY
791
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.34M | 0.01% |
220,945
+2,662
| +1% | +$53.4K |
|
792
Kinder Morgan
KMI
$69B
| $4.33M | 0.01% |
+260,395
| New | +$4.63M |
|
793
Perrigo
PRGO
$1.98B
| $4.33M | 0.01% |
121,325
-464,829
| -79% | -$18.7M |
|
794
Rockwell Automation
ROK
$47.7B
| $4.31M | 0.01% |
20,019
-289,392
| -94% | -$67.5M |
|
795
Verisk Analytics
VRSK
$24.7B
| $4.29M | 0.01% |
+25,136
| New | +$4.7M |
|
796
Carlyle Secured Lending
CGBD
$788M
| $4.25M | 0.01% |
371,365
-69,402
| -16% | -$942K |
|
|
AVB
797
DELISTED
AvalonBay Communities
AVB
| $4.24M | 0.01% |
+23,030
| New | +$4.65M |
|
798
Fate Therapeutics
FATE
$292M
| $4.24M | 0.01% |
+189,067
| New | +$5.46M |
|
799
Halozyme
HALO
$12.3B
| $4.24M | 0.01% |
107,139
-463,292
| -81% | -$20.5M |
|
800
Codexis
CDXS
$182M
| $4.23M | 0.01% |
697,384
+136,028
| +24% | +$1.09M |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.